These findings suggest that target gene therapy mediated by vaccinia virus may provide a powerful tool for cancer treatment and VG9-IL-24 holds a significant promise as a novel strategy for HCC therapy. The gene discussed is IL24; the disease is hepatocellular carcinoma.